Clinical Trial Update: Intranasal Dexmedetomidine vs Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intranasal dexmedetomidine versus intranasal midazolam as anxiolysis before pediatric laceration repair; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Laceration

Drugs mentioned

• intranasal Dexmedetomidine (dexmedetomidine)
• intranasal Midazolam (midazolam)

Snippet

Sponsor: University of Pittsburgh | Conditions: Laceration, Anxiety | Phase 4 | Status: COMPLETED | Results posted: 2017-03-10